- Home
- RBOT
as 11-26-2025 2:30pm EST
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 17.0M | IPO Year: | N/A |
| Target Price: | $7.00 | AVG Volume (30 days): | 82.0K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -9.03 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.44 - $19.00 | Next Earning Date: | 11-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Vicarious Surgical Inc. News
RBOT Breaking Stock News: Dive into RBOT Ticker-Specific Updates for Smart Investing
Business Wire
9 days ago
Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference
MedTech Dive
14 days ago
Vicarious says it will outsource some robot development functions
GuruFocus.com
15 days ago
Vicarious Surgical Inc (RBOT) Q3 2025 Earnings Call Highlights: Strategic Cost Management and ...
Business Wire
16 days ago
Vicarious Surgical Reports Third Quarter 2025 Financial Results
Business Wire
21 days ago
Vicarious Surgical to Report Third Quarter 2025 Financial Results on November 12, 2025
Business Wire
a month ago
Vicarious Surgical to Report Third Quarter 2025 Financial Results on November 13, 2025
Business Wire
2 months ago
Vicarious Surgical Announces Pricing of $5.9 Million Registered Direct Offering
Business Wire
5 months ago
Vicarious Surgical Announces Election of New Directors
Compare RBOT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RBOT Vicarious Surgical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.